Increased expression of GJB2 was associated with poor prognosis in various tumors, including breast cancer, pancreatic cancer, lung adenocarcinoma, and esophageal squamous cell carcinoma (10, 31–33). This evidence concerns the gene GJB2 and breast cancer.